Invitrogen licenses stem cell line from Buck Institute

The stem cell line, called BG01 Olig2-GFP, is engineered to track the Olig2 gene, a neural lineage marker. The Olig2 gene controls a protein that maintains a neural stem cell’s ability to replicate early in brain development, and then directs it to form a particular type of neural cell.

Joydeep Goswami, vice president of primary and stem cell systems at Invitrogen, said: “This line of stem cells adds to Invitrogen’s expanding portfolio of engineered stem cells. We plan to not only provide the line to customers, but also to further develop products from the line that will serve as valuable tools in neural stem cell research.”